Editas Medicine, Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $13.7M | $6.1M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $83.2M | $57.0M |
| SG&A Expense | $50.5M | $46.3M |
| Operating Income | $-119.9M | $-97.2M |
| Operating Margin | -873.6% | -1,605.6% |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | $-120.3M | $-97.2M |
| Net Margin | -876.5% | -1,605.5% |
| EPS (Basic) | $-2.98 | $-3.02 |
| EPS (Diluted) | $-2.98 | $-3.02 |
| Shares Outstanding (Basic) | 44.5M | 35.8M |
| Shares Outstanding (Diluted) | 44.5M | 35.8M |
| Dividends Per Share | — | — |